Resources
Resources provided by Halteres Associates highlight the thought leadership and deep group expertise our team offers its clients and constituents.
Tools for COVID-19 Diagnostics Development and Application
- Overview of COVID-19 Diagnostic Tools
- Value Creation Roadmap for Diagnostic Developers
- COVID-19 Use Case Definitions
- COVID-19 Use Settings (Storyboards)
Diagnostics Reports
- November 2020 Report on Landscape of Companies for Influenza Tests
- March 2020 COVID-19 Diagnostic Use Cases (Use Case Tables)
- January 2018 Diagnostics Report Issue 2
- November 2017 Diagnostics Report Issue 1
Presentations
- Roadmap to Value Creation in Molecular Diagnostics
- Case Study: Strategic Options - Clinical Diagnostics for Iconix Biosciences, Inc.
- High Impact Diagnostics
- POC Testing - The Time is Now
Publications
- Post-Mortems on Diagnostic Testing Start-ups: Reports of Commercial Successes and Failures and the Case of the Zombie Life Science Company, BMJ Innovations, 2020
- Usability assessment of seven HIV self-test devices conducted with lay-users in Johannesburg, South Africa, PLOS ONE, 2020.
- Requirements for High Impact Diagnostics in the Developing World Nature, 2006
Response
- Primum Non Nocere: Is the Performance of Available SARS-CoV-2 RNA and Immunoassays Good Enough To Do No Harm? AACC Artery Blog, April 14, 2020
White Papers
- An Assessment of the Technological Issues and Options for Point-Of-Care Diagnostic Tests in Resource-Limited Settings
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Status of Technologies and Approaches for Biomarker Discovery
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Diagnosis of Bacterial and Severe Acute Lower Respiratory Tract Infection
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Diagnosis of Giardia lamblia, Cryptosporidium parvum, and Enteroaggregative Escherichia coli in Children with Diarrhea as a Surrogate of Stunting
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Diagnosis of HIV Infection in Infants Less than Eighteen Months of Age
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Rapid, Home-based Diagnosis of Malaria in Symptomatic Individuals and Screening of Asymptomatic Pregnant Women
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Diagnosis of Chlamydia trachomatis and Neisseria gonorrhea Infection in High-risk Women
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Diagnosis of Syphilis in Asymptomatic Pregnant Women
- Biomarkers for Infectious Disease Diagnostics in the Developing World: Diagnosis of Tuberculosis in HIV Positive and HIV Negative Individuals
Halteres Associates has many resources available to help guide the development, commercialization and realization of value for new innovations in diagnostics, health and wellness, and global health.